Manipal Health Enterprises authorizes KMPs to decide materiality
Manipal Health Enterprises Limited has empowered its Key Managerial Personnel, including MD Dilip Jose and CFO Sameer Agarwal, to determine the materiality of events for regulatory disclosures. This authorization under SEBI Listing Regulations aims to streamline compliance and ensure timely investor communication. The details were filed with BSE and NSE on August 5, 2026.

*this image is generated using AI for illustrative purposes only.
The Board of Directors of manipal health enterprises limited has authorized its Key Managerial Personnel (KMPs) to determine the materiality of events or information and make the requisite disclosures to stock exchanges. This decision streamlines the company's compliance process under Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. By delegating this authority, the company ensures timely dissemination of material information to investors while adhering to regulatory frameworks.
This authorization applies to four senior executives who will now jointly assess whether specific events or information meet the threshold for public disclosure. The move aligns with the company’s Policy on Determination of Materiality of Events or Information. The intimation was submitted to BSE Limited and the National Stock Exchange of India Limited on August 5, 2026.
Authorized Key Managerial Personnel
The following executives have been granted the authority to determine materiality:
| Name | Designation | Contact Details |
|---|---|---|
| Dilip Jose | Managing Director and Chief Executive Officer | Mobile: +91 80493 60300; E-mail: legalcs@maipalhospitals.com |
| Sameer Agarwal | Chief Financial Officer | Not disclosed |
| Karthik Rajagopal | Chief Operating Officer | Not disclosed |
| Sathish K R | Company Secretary and Compliance Officer | Not disclosed |
Dilip Jose serves as the Managing Director and Chief Executive Officer, providing strategic oversight for these determinations. Sameer Agarwal acts as the Chief Financial Officer, bringing financial expertise to the assessment of materiality. Karthik Rajagopal, the Chief Operating Officer, contributes operational insights. Sathish K R, the Company Secretary and Compliance Officer, ensures that all disclosures comply with regulatory requirements.
Regulatory Context
Regulation 30 of the SEBI Listing Regulations mandates listed entities to promptly disclose any price-sensitive information to stock exchanges. Paragraph 5 of Regulation 30 allows companies to delegate the determination of materiality to their Board or a committee thereof, or to Key Managerial Personnel. Manipal Health Enterprises Limited has chosen the latter approach, empowering its top management to act swiftly in identifying and disclosing material events.
The details of these authorized personnel are available on the company’s website for transparency. This structure aims to enhance the efficiency of corporate communications and ensure that stakeholders receive accurate and timely information regarding significant developments affecting the company.
What the Numbers Show
While this filing does not contain financial metrics, the delegation of materiality determination reflects a governance choice to centralize disclosure decisions within the executive team. This can lead to faster response times to emerging events compared to requiring full Board approval for each assessment. The inclusion of both operational (Karthik Rajagopal) and financial (Sameer Agarwal) leaders alongside the CEO suggests a holistic approach to evaluating what constitutes material information for investors.
Historical Stock Returns for Manipal Health Enterprises
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.66% | +14.15% | +14.15% | +14.15% | +14.15% | +14.15% |
How might this delegation of authority impact the speed and frequency of material disclosures compared to previous Board-level assessments?
What specific operational or financial thresholds have been defined in the company's policy to guide these four executives in determining materiality?
Could this centralized decision-making structure increase the risk of selective disclosure or conflicts of interest among the Key Managerial Personnel?



























